AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-165 Cr | ₹-224 Cr | ₹-164 Cr | ₹-150 Cr | ₹-72 Cr |
What is the latest Cash Flow from Investing Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-165 Cr |
| Mar2024 | ₹-224 Cr |
| Mar2023 | ₹-164 Cr |
| Mar2022 | ₹-150 Cr |
| Mar2021 | ₹-72 Cr |
How is Cash Flow from Investing Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-165 Cr | Negative | |
| Mar2024 | ₹-224 Cr | Negative | |
| Mar2023 | ₹-164 Cr | Negative | |
| Mar2022 | ₹-150 Cr | Negative | |
| Mar2021 | ₹-72 Cr | - | |
Compare Cash Flow from Investing Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,988.4 Cr | 1.2% | 1.2% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 1.2% |
1.2% |
-10% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses